Biotech | March 14, 2022
Clarivate deals report highlights emerging trends in biopharma deal-making
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
The money will be donated to the United Nations Children’s Fund (UNICEF)
The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards
Subscribe To Our Newsletter & Stay Updated
